Financhill
Buy
74

BSX Quote, Financials, Valuation and Earnings

Last price:
$105.33
Seasonality move :
4.94%
Day range:
$104.35 - $105.48
52-week range:
$65.34 - $107.17
Dividend yield:
0%
P/E ratio:
84.54x
P/S ratio:
9.38x
P/B ratio:
7.16x
Volume:
4.2M
Avg. volume:
6.3M
1-year change:
59.11%
Market cap:
$155.9B
Revenue:
$16.7B
EPS (TTM):
$1.25

Analysts' Opinion

  • Consensus Rating
    Boston Scientific has received a consensus rating of Buy. The company's average rating is a Buy based on 23 Buy ratings, 3 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $115.49, Boston Scientific has an estimated upside of 9.3% from its current price of $105.36.
  • Price Target Downside
    According to analysts, the lowest downside price target is $84.00 representing 20.51% downside risk from its current price of $105.36.

Fair Value

  • According to the consensus of 26 analysts, Boston Scientific has 9.3% upside to fair value with a price target of $115.49 per share.

BSX vs. S&P 500

  • Over the past 5 trading days, Boston Scientific has underperformed the S&P 500 by -0.77% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Boston Scientific does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Boston Scientific has grown year-over-year revenues for 16 quarters straight. In the most recent quarter Boston Scientific reported revenues of $4.6B.

Earnings Growth

  • Boston Scientific has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Boston Scientific reported earnings per share of $0.38.
Enterprise value:
166.4B
EV / Invested capital:
5.10x
Price / LTM sales:
9.38x
EV / EBIT:
64.32x
EV / Revenue:
9.94x
PEG ratio (5yr expected):
5.03x
EV / Free cash flow:
70.35x
Price / Operating cash flow:
66.39x
Enterprise value / EBITDA:
43.15x
Gross Profit (TTM):
$11.5B
Return On Assets:
4.96%
Net Income Margin (TTM):
11.05%
Return On Equity:
8.96%
Return On Invested Capital:
5.97%
Operating Margin:
17.32%
Trailing 12 Months Fiscal Quarters
Period Ending 2022-12-31 2023-12-31 2024-12-31 2023-12-31 2024-12-31
Income Statement
Revenue $12.7B $14.2B $16.7B $3.7B $4.6B
Gross Profit $8.7B $9.9B $11.5B $2.6B $3.1B
Operating Income $2B $2.4B $3B $618M $790M
EBITDA $2.7B $3.4B $3.9B $883M $1B
Diluted EPS $0.45 $1.07 $1.25 $0.34 $0.38
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Balance Sheet
Current Assets $6.7B $6.3B $5.8B $6.5B $6.9B
Total Assets $30.8B $32.2B $32.5B $35.1B $39.4B
Current Liabilities $3.7B $4.3B $3.8B $4.9B $6.4B
Total Liabilities $15.5B $15.6B $14.9B $15.6B $17.4B
Total Equity $15.3B $16.6B $17.6B $19.5B $22B
Total Debt $9.1B $9.1B $8.9B $9.1B $10.6B
Trailing 12 Months Fiscal Quarters
Period Ending 2022-12-31 2023-12-31 2024-12-31 2023-12-31 2024-12-31
Cash Flow Statement
Cash Flow Operations $1.5B $2.5B $3.4B $957M $1.5B
Cash From Investing -$2B -$2.6B -$5.7B -$1.1B -$3.7B
Cash From Financing -$548M $5M $1.8B $15M $214M
Free Cash Flow $914M $1.7B $2.4B $690M $1.2B
BSX
Sector
Market Cap
$155.9B
$44.2M
Price % of 52-Week High
98.6%
48.19%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.68%
1-Year Price Total Return
60.54%
-35.43%
Beta (5-Year)
0.804
0.747
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Technicals

8-day SMA
Sell
Level $105.82
200-day SMA
Buy
Level $84.67
Bollinger Bands (100)
Buy
Level 84.99 - 99.11
Chaikin Money Flow
Buy
Level 1B
20-day SMA
Buy
Level $104.23
Relative Strength Index (RSI14)
Buy
Level 71.01
ADX Line
Buy
Level 36.89
Williams %R
Neutral
Level -23.1839
50-day SMA
Buy
Level $97.05
MACD (12, 26)
Buy
Level 2.49
25-day Aroon Oscillator
Buy
Level 60
On Balance Volume
Neutral
Level 772.1M

Financial Scores

Buy
Altman Z-Score (Annual)
Level (5.2964)
Buy
CA Score (Annual)
Level (0.2571)
Buy
Beneish M-Score (Annual)
Level (-2.5162)
Buy
Momentum Score
Level (9)
Buy
Ohlson Score
Level (-1.6963)
Buy
Piotroski F Score (Annual)
Level (7)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (8)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.

Stock Forecast FAQ

In the current month, BSX has received 23 Buy ratings 3 Hold ratings, and 0 Sell ratings. The BSX average analyst price target in the past 3 months is $115.49.

  • Where Will Boston Scientific Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Boston Scientific share price will rise to $115.49 per share over the next 12 months.

  • What Do Analysts Say About Boston Scientific?

    Analysts are divided on their view about Boston Scientific share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Boston Scientific is a Sell and believe this share price will drop from its current level to $84.00.

  • What Is Boston Scientific's Price Target?

    The price target for Boston Scientific over the next 1-year time period is forecast to be $115.49 according to 26 Wall Street analysts, 23 of them rate the stock a Buy, 0 rate the stock a Sell, and 3 analysts rate the stock a Hold.

  • Is BSX A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Boston Scientific is a Buy. 23 of 26 analysts rate the stock a Buy at this time.

  • How Can I Buy Shares Of BSX?

    You can purchase shares of Boston Scientific via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Boston Scientific shares.

  • What Is The Boston Scientific Share Price Today?

    Boston Scientific was last trading at $105.33 per share. This represents the most recent stock quote for Boston Scientific. Yesterday, Boston Scientific closed at $105.36 per share.

  • How To Buy Boston Scientific Stock Online?

    In order to purchase Boston Scientific stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

What Is SoFi Worth?
What Is SoFi Worth?

Since SoFi’s CEO began snapping up shares of the student…

Is CVX a Buy, Sell or Hold?
Is CVX a Buy, Sell or Hold?

Energy giant Chevron Corporation (NYSE:CVX) has long been a pure-play…

What Will NVIDIA Stock Be Worth in 2030?
What Will NVIDIA Stock Be Worth in 2030?

NVIDIA (NASDAQ:NVDA) has been by far one of the best…

Stock Ideas

Buy
65
Is AAPL Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 40x

Buy
60
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 117x

Buy
51
Is MSFT Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 35x

Alerts

Sell
17
CE alert for Feb 21

Celanese [CE] is down 4.21% over the past day.

Sell
22
GLBE alert for Feb 20

Global E Online [GLBE] is down 8.41% over the past day.

Buy
72
HIMS alert for Feb 20

Hims & Hers Health [HIMS] is down 3.39% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock